Silibinin reduces depression in miceSilibinin ameliorates depression/anxiety-like behaviors of Parkinson's disease mouse model and is associated with attenuated STING-IRF3-IFN-β pathway activation and neuroinflammation.
We investigated the impact of silibinin, a natural compound from Silybum marianum, on depression and anxiety in mice with Parkinson's disease. Through various behavioral tests, we found that silibinin significantly reduced depressive and anxious behaviors caused by MPTP, a chemical used to induce these symptoms.
Additionally, silibinin helped repair neuronal damage in the hippocampus and restored levels of important mood-regulating neurotransmitters. It also reduced markers of neuroinflammation linked to depression, suggesting silibinin may hold promise as a treatment for these conditions in Parkinson's.
Read More
Silymarin shows promise against stress-induced depressionTherapeutic potential of silymarin in chronic unpredictable mild stress induced depressive-like behavior in mice.
We explored the impact of silymarin, a compound from the Silybum marianum plant, on depression-like behaviors in mice exposed to chronic stress over four weeks. By administering different doses of silymarin alongside fluoxetine, we observed behavioral and biochemical changes in the mice. The results showed that silymarin reversed several negative effects caused by stress, including decreased serotonin and dopamine levels, and improved neurobiological markers like BDNF. This suggests that silymarin could play a beneficial role in alleviating depression by enhancing critical neurochemical pathways.
Read More
Silymarin shows promise for depressionPossible involvement of nitric oxide in antidepressant-like effect of silymarin in male mice.
We investigated whether silymarin, derived from milk thistle, has antidepressant-like effects in male mice. Administered in varying doses before tests, silymarin significantly reduced immobility times, indicating potential antidepressant activity.
Notably, the study found that nitric oxide may play a role in this effect, as inhibiting nitric oxide synthesis reversed silymarin’s impact. However, it’s important to note that this study only involved animal models, and results may not directly translate to humans.
Read More
Silibinin boosts neurogenesis, fights depressionSilibinin exerts antidepressant effects by improving neurogenesis through BDNF/TrkB pathway.
We explored the potential antidepressant effects of silibinin, a compound from Silybum marianum, by looking into how it impacts brain health in depression. Supporting our study, we found that silibinin improved behaviors in mice showing depressive symptoms.
Our findings connected its positive effects to increased growth of neural stem cells and better signaling in the BDNF/TrkB pathway, which is crucial for brain function. These results suggest that silibinin could be a valuable supplement for enhancing neurogenesis in those struggling with depression.
Read More
Silibinin shows potential in depressionSilibinin ameliorates anxiety/depression-like behaviors in amyloid β-treated rats by upregulating BDNF/TrkB pathway and attenuating autophagy in hippocampus.
We investigated whether silibinin, a compound extracted from milk thistle, could alleviate anxiety and depression-like behaviors in rats exposed to amyloid β. Our findings showed that silibinin significantly reduced these negative behaviors as indicated by multiple tests.
Additionally, it helped protect against cellular damage in the hippocampus, revealing its potential to enhance important neurological pathways. While promising, these results are based on animal studies, highlighting the need for further research to determine silibinin's effectiveness in humans.
Read More